Senate Health Committee To Revisit 340B Issues, Solutions

By Gabrielle Wanneh / October 17, 2025 at 5:45 PM

Months after unveiling the findings of a years-long investigation of the growth of the 340B drug discount program and the impact certain operational issues and covered entity practices have had on patients, the Senate health committee is due to revisit ongoing concerns with the program next week.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.